 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
18 News |  |
- EXC 001 / Pfizer
Enrollment change, Trial termination, Trial primary completion date, Surgery: A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study (clinicaltrials.gov) - Jan 28, 2015
P2, N=10, Terminated, Sponsor: Pfizer
N=103 --> 10 | Recruiting --> Terminated | Trial primary completion date: Oct 2015 --> Dec 2014; B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.
- |||| EXC 001 / Pfizer
Enrollment open, Trial initiation date, Surgery: A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study (clinicaltrials.gov) - Dec 19, 2014
P2, N=103, Recruiting, Sponsor: Pfizer
No safety concerns identified. Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Dec 2014
- |||| EXC 001 / Pfizer
Trial completion, Surgery: Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery (clinicaltrials.gov) - Dec 17, 2014
P2, N=100, Completed, Sponsor: Pfizer
Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Dec 2014 Active, not recruiting --> Completed
- ||| EXC 001 / Pfizer
Enrollment change, Surgery: A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study (clinicaltrials.gov) - Sep 28, 2014
P2, N=103, Not yet recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed N=50 --> 103
- EXC 001 / Pfizer
Trial primary completion date, Surgery: A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study (clinicaltrials.gov) - Sep 8, 2014
P2, N=50, Not yet recruiting, Sponsor: Pfizer
N=50 --> 103 Trial primary completion date: Feb 2016 --> Nov 2015
- | EXC 001 / Pfizer
New P2 trial, Surgery: A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study (clinicaltrials.gov) - Aug 1, 2014
P2, N=50, Not yet recruiting, Sponsor: Pfizer
- ||| EXC 001 / Pfizer
Enrollment closed, Surgery: Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery (clinicaltrials.gov) - May 13, 2014
P2, N=100, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: Feb 2016 --> Nov 2015 Recruiting --> Active, not recruiting
- | EXC 001 / Pfizer
Enrollment change, Surgery: Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001 (clinicaltrials.gov) - Dec 9, 2013
P2, N=14, Completed, Sponsor: Pfizer
Recruiting --> Active, not recruiting N=150 --> 14
- | EXC 001 / Pfizer
Trial completion, Surgery: Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001 (clinicaltrials.gov) - Dec 9, 2013
P2, N=14, Completed, Sponsor: Pfizer
N=150 --> 14 Active, not recruiting --> Completed
- | EXC 001 / Pfizer
Trial completion: Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults (clinicaltrials.gov) - Jun 18, 2013
P1, N=32, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | EXC 001 / Pfizer
New P1 trial: Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults (clinicaltrials.gov) - Dec 18, 2012
P1, N=32, Completed, Sponsor: Pfizer
- |||| EXC 001 / Pfizer
Enrollment open, Surgery: Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery (clinicaltrials.gov) - Dec 16, 2012
P2, N=100, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| EXC 001 / Pfizer
New P2 trial, Surgery: Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery (clinicaltrials.gov) - Nov 19, 2012
P2, N=100, Recruiting, Sponsor: Pfizer
- |||| EXC 001 / Pfizer
Trial completion, Surgery: Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery (clinicaltrials.gov) - Jun 27, 2012
P2, N=68, Completed, Sponsor: Pfizer
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | EXC 001 / Pfizer
Enrollment change, Surgery: Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery (clinicaltrials.gov) - Feb 29, 2012
P2, N=25, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed N=40 --> 25
- | EXC 001 / Pfizer
New P2 trial, Surgery: Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001 (clinicaltrials.gov) - Dec 15, 2011
P2, N=14, Completed, Sponsor: Pfizer